ABI

59.68

0%↓

CDI

441

+0.36%↑

128

+1.15%↑

40.19

-0.4%↓

HEIO

61.15

+0.49%↑

ABI

59.68

0%↓

CDI

441

+0.36%↑

128

+1.15%↑

40.19

-0.4%↓

HEIO

61.15

+0.49%↑

ABI

59.68

0%↓

CDI

441

+0.36%↑

128

+1.15%↑

40.19

-0.4%↓

HEIO

61.15

+0.49%↑

ABI

59.68

0%↓

CDI

441

+0.36%↑

128

+1.15%↑

40.19

-0.4%↓

HEIO

61.15

+0.49%↑

ABI

59.68

0%↓

CDI

441

+0.36%↑

128

+1.15%↑

40.19

-0.4%↓

HEIO

61.15

+0.49%↑

Home・Akciju saraksts・Fluidra SA

Fluidra SA

Slēgts

SektorsPatēriņa aizsardzības

19.94 -0.7

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

19.7

Max

20.12

Galvenie mērījumi
By Trading Economics
Ienākumi	-9.6M 17M
Pārdošana	-38M 460M
P/E Sektora vidējais	20.968 27.787
EPS	0.19
Dividenžu ienesīgums	3.46
Peļņas marža	3.775
Darbinieki	6,767
EBITDA	365M 460M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+34.08% upside

Dividendes
By Dow Jones
Dividenžu ienesīgums Sektora vidējais	3.46% 3.82%
Nākamie ieņēmumi	2026. g. 6. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-862M 3.7B
Iepriekšējā atvēršanas cena	20.64
Iepriekšējā slēgšanas cena	19.94

Ziņu noskaņojums

By Acuity

29%

71%

29 / 131 Rangs Consumer defensive

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

20.12 / 20.22 Atbalsts un pretestība

Fluidra SA Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 31. marts 23:31 UTC

Karstas akcijas

Stocks to Watch: Nike, RH, NCino

2026. g. 31. marts 22:35 UTC

Peļņas

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

2026. g. 1. apr. 00:00 UTC

Iegādes, apvienošanās, pārņemšana

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

2026. g. 31. marts 23:50 UTC

Iegādes, apvienošanās, pārņemšana

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

2026. g. 31. marts 23:43 UTC

Tirgus saruna

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

2026. g. 31. marts 23:33 UTC

Tirgus saruna

Galvenie ziņu notikumi

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

2026. g. 31. marts 23:21 UTC

Peļņas

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

2026. g. 31. marts 23:14 UTC

Tirgus saruna

Peļņas

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

2026. g. 31. marts 23:12 UTC

Tirgus saruna

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

2026. g. 31. marts 22:36 UTC

Peļņas

China Vanke 2025 Loss Widens >000002.SZ

2026. g. 31. marts 22:36 UTC

Peļņas

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

2026. g. 31. marts 22:36 UTC

Peļņas

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

2026. g. 31. marts 22:36 UTC

Peļņas

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

2026. g. 31. marts 22:36 UTC

Peļņas

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

2026. g. 31. marts 21:46 UTC

Iegādes, apvienošanās, pārņemšana

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

2026. g. 31. marts 21:36 UTC

Tirgus saruna

West African Resources's Costs Higher Than Bull Expected -- Market Talk

2026. g. 31. marts 21:35 UTC

Peļņas

Nike Expects China Sales Down 20% in 4Q, CFO Says

2026. g. 31. marts 21:35 UTC

Peļņas

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

2026. g. 31. marts 21:35 UTC

Peļņas

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

2026. g. 31. marts 21:33 UTC

Iegādes, apvienošanās, pārņemšana

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

2026. g. 31. marts 21:33 UTC

Peļņas

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

2026. g. 31. marts 21:32 UTC

Peļņas

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

2026. g. 31. marts 21:28 UTC

Peļņas

Nike Expects to End 4Q With Elevated Inventory, CFO Says

2026. g. 31. marts 21:26 UTC

Peļņas

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

2026. g. 31. marts 21:25 UTC

Peļņas

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

2026. g. 31. marts 21:24 UTC

Tirgus saruna

Peļņas

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

2026. g. 31. marts 21:22 UTC

Peļņas

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

2026. g. 31. marts 21:22 UTC

Peļņas

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

2026. g. 31. marts 21:21 UTC

Peļņas

Nike's Digital Channel Still Too Promotional, CFO Says

2026. g. 31. marts 21:20 UTC

Peļņas

Nike CEO: Converse Remains Important to Portfolio

Salīdzinājums

Cenas izmaiņa

Fluidra SA Prognoze

Cenas mērķis

By TipRanks

34.08% augšup

Prognoze 12 mēnešiem

Vidējais 26.87 EUR 34.08%

Augstākais 31 EUR

Zemākais 21.5 EUR

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Fluidra SA — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

6 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 6 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Fluidra SA — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

20.12 / 20.22Atbalsts un pretestība

Recent bearish events outweigh bullish events.

All events are bearish.

Recent bearish events outweigh bullish events.

Noskaņojums

By Acuity

29 / 131 Rangs Patēriņa aizsardzības

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Fluidra SA

Fluidra, S.A., together with its subsidiaries, manufactures, distributes, and markets accessories and machinery for swimming-pools, irrigation and water treatment, and purification for residential and commercial pool market worldwide. The company provides basic pool fittings, which includes ladders, showers, pumps, valves, filters, heaters, grilles, water lighting, cleaning accessories, and others; robotic pool cleaners, pool covers, fire and water features, slides, springboards, and connected products; pool fittings spare parts; above-ground pools, and natural ponds and pools; and swim spas, saunas and steam baths, sensory showers, and Nordic baths. It also provides commercial pool and wellness water facilities for public use, including hotel and resort pools, water parks, municipal and competition pools, spa and wellness centers, fountains, lagoons, and aquariums; and develops turnkey aquatic projects. In addition, the company offers pool water treatment products; irrigation accessories for gardens; and manufactures and distributes high-end valves and accessories to build pool hydraulic circuits. It sells its products under the Astral Pool, Zodiac, Jandy, Polaris, GRE, Cepex, CTX Professional, Certikin, and Piscine Laghetto brands. The company was formerly known as Aquaria de Inv. Corp., S.L. and changed its name to Fluidra, S.A. in September 2007. Fluidra, S.A. was founded in 1969 and is headquartered in Sant Cugat del Vallès, Spain.